We are live on ! Find out more
BlackRock Advisors

BlackRock Advisors Portfolio holdings

AUM $98.8B Turnover 6.58%
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.8B
AUM Growth
+$1.56B
Cap. Flow
-$4.24B
Cap. Flow %
-4.3%
Top 10 Hldgs %
17.3%
Holding
3,843
New
120
Increased
1,850
Reduced
1,294
Closed
133
Avg Time Held Equity + Options
2.9 years
Top 10 Avg Time Held Equity + Options
1.2 years
Top 20 Avg Time Held Equity + Options
1.8 years
Avg Time Held Equity only
2.9 years
Top 10 Avg Time Held Equity only
1.3 years
Top 20 Avg Time Held Equity only
1.9 years

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$263M
2
PFE icon
Pfizer
PFE
+$251M
3
HCA icon
HCA Healthcare
HCA
+$175M
4
AMZN icon
Amazon
AMZN
+$156M
5
DD icon
DuPont de Nemours
DD
+$153M

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$371M
2
GLD icon
SPDR Gold Trust
GLD
+$340M
3
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$324M
4
RTN
Raytheon Company
RTN
+$273M
5
LLY icon
Eli Lilly
LLY
+$210M

Sector Composition

Rank Sector Weight
1 Financials 17.28%
2 Healthcare 15.6%
3 Miscellaneous 13.75%
4 Technology 10.68%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BSTG
3651
DELISTED
Biostage, Inc. Common Stock
BSTG
$3K ﹤0.01%
3,656
– –
2013 Q4
12 quarters
TPLM
3652
DELISTED
Triangle Petroleum Corporation
TPLM
$3K ﹤0.01%
11,728
-108,030
-90% -$29.5K
2013 Q2
14 quarters
FCE.B
3653
DELISTED
Forest City Realty Trust, Inc.
FCE.B
$3K ﹤0.01%
+124
New +$2.78K
2016 Q4
0 quarters
OREX
3654
DELISTED
Orexigen Therapeutics, Inc.
OREX
$3K ﹤0.01%
1,808
– –
2013 Q2
14 quarters
GNVC
3655
DELISTED
GenVec, Inc.
GNVC
$3K ﹤0.01%
826
-1
-0.1% -$3
2013 Q2
14 quarters
KALV icon
3656
DELISTED
KalVista Pharmaceuticals
KALV
$2K ﹤0.01%
258
– –
2015 Q2
6 quarters
OCGN icon
3657
Ocugen
OCGN
$265M
$2K ﹤0.01%
23
– –
2015 Q2
6 quarters
VIVO icon
3658
VivoPower PLC
VIVO
$67.2M
$2K ﹤0.01%
+35
New +$2.25K
2016 Q4
0 quarters
SEEL icon
3659
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
2013 Q2
14 quarters
EVFM
3660
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$2K ﹤0.01%
18
– –
2015 Q2
6 quarters
CLRBZ icon
3661
DELISTED
Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
$2K ﹤0.01%
5,847
– –
2016 Q2
2 quarters
TRNX
3662
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
– –
0
– –
2015 Q4
4 quarters
FPP.WS
3663
DELISTED
FieldPoint Petroleum Corporation Common Stock Purchase Warrants
FPP.WS
$2K ﹤0.01%
56,448
– –
2015 Q3
5 quarters
CRTN
3664
DELISTED
Cartesian, Inc.
CRTN
$2K ﹤0.01%
2,116
– –
2014 Q3
9 quarters
CDOR
3665
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$2K ﹤0.01%
152
– –
2015 Q3
5 quarters
ACUR
3666
DELISTED
Acura Pharmaceuticals
ACUR
$2K ﹤0.01%
3,204
– –
2013 Q2
14 quarters
PERF icon
3667
DELISTED
Perfumania Holdings, Inc.
PERF
$2K ﹤0.01%
1,362
– –
2013 Q2
14 quarters
ATLC icon
3668
Atlanticus Holdings
ATLC
$1.4B
$1K ﹤0.01%
251
– –
2013 Q2
14 quarters
CVM icon
3669
CEL-SCI Corp
CVM
$31.5M
$1K ﹤0.01%
29
– –
2013 Q4
12 quarters
EFT icon
3670
Eaton Vance Floating-Rate Income Trust
EFT
$281M
$1K ﹤0.01%
100
– –
2014 Q1
11 quarters
GNK icon
3671
Genco Shipping & Trading
GNK
$1.07B
$1K ﹤0.01%
177
– –
2015 Q3
5 quarters
AGIG icon
3672
Abundia Global Impact Group
AGIG
$36.6M
$1K ﹤0.01%
41
– –
2013 Q2
14 quarters
MBOT icon
3673
Microbot Medical
MBOT
$63.8M
$1K ﹤0.01%
16
– –
2013 Q2
14 quarters
TNXP icon
3674
Tonix Pharmaceuticals
TNXP
$104M
– –
0
– –
2015 Q2
6 quarters
USAU icon
3675
US Gold Corp
USAU
$196M
$1K ﹤0.01%
7
– –
2013 Q2
14 quarters
145 146
147
148 149

Similar funds

BlackRock Investment Management
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
BlackRock Japan
BlackRock Japan Tokyo, Japan $30.3B AUM 13.85% 1-Year Est. Return
Institutional Capital
Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return
EverPoint Asset Management
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
MSI Financial Services
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return
CIM
Calvert Investment Management Bethesda, Maryland $2.67B AUM 16.23% 1-Year Est. Return
KAM
Keeley Asset Management Chicago, Illinois $2.35B AUM 26.92% 1-Year Est. Return
WC
Weatherbie Capital Boston, Massachusetts $797M AUM 23.31% 1-Year Est. Return

BlackRock Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, BlackRock Advisors held 3,843 positions worth $98.8B, up 1.6% from $97.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

BlackRock Advisors withdrew a net $4.24B in Q4 2016, closing 133 positions and reducing 1,294 holdings. Its most notable exit was American Capital Ltd, an estimated $185M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, BlackRock Advisors opened a new position in iShares 5-10 Year Investment Grade Corporate Bond ETF worth $64.5M.

  • BlackRock Advisors's largest Q4 2016 buy was iShares 5-10 Year Investment Grade Corporate Bond ETF: 1,192,866 shares worth $64.5M.
  • BlackRock Advisors added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2016, an estimated $263M increase.
  • BlackRock Advisors's biggest Q4 2016 reduction was GE Aerospace, cutting an estimated $371M.
  • BlackRock Advisors fully exited American Capital Ltd in Q4 2016, selling an estimated $185M.
  • BlackRock Advisors's ten largest holdings make up 17% of its $98.8B portfolio in Q4 2016.
  • BlackRock Advisors opened 120 new positions and closed 133 in Q4 2016.
  • BlackRock Advisors's portfolio value rose 1.6% quarter-over-quarter to $98.8B.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.